藥品參考
Revakinagene taroretcel
Revakinagene taroretcel is a medicine in the class miscellaneous.
- 藥物類別: Miscellaneous
最後更新 來源: US FDA label
僅供醫療專業人員參考。本頁為簡要摘要，並非醫療建議，亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。
本頁的臨床內容僅提供英文版。
重點資訊
- 藥物類別
- Miscellaneous
- 商品名
- 1
- 國家與市場
- 1
作用方式
The implant secretes recombinant human ciliary neurotrophic factor (rhCNTF). Exogenous CNTF is thought to target Müller glia and trigger signaling that may promote photoreceptor survival. The mechanism is not completely understood.
成人常用劑量（仿單摘要）
Idiopathic macular telangiectasia type 2: one implant per affected eye (200,000 to 440,000 allogeneic RPE cells expressing rhCNTF), single surgical intravitreal implantation by a qualified ophthalmologist
懷孕與哺乳
- 懷孕
- Unknown An eye implant of cells releasing ciliary neurotrophic factor (CNTF); no data in pregnant women, and not known if it raises CNTF above natural levels. CNTF under the skin caused no birth defects in rats or rabbits, but fewer implantations and live fetuses in rabbits. Use only if clearly needed.
- 哺乳
- Unknown No data on milk or infant effects; no LactMed record. Systemic exposure from the eye implant is not known to rise above natural CNTF levels. US label: weigh benefits of breastfeeding against the mother's need.
已通報的副作用
- Conjunctival hemorrhage
- Delayed dark adaptation
- Foreign body sensation
- Eye pain
- Suture related complications
- Miosis
禁忌症
- Active or suspected ocular or periocular infections
- Known hypersensitivity to Endothelial Serum Free Media (Endo-SFM)
哪些人需要特別留意
- Severe vision loss (3 or more lines, ≥15 ETDRS letters) has occurred; monitor patients
- Infectious endophthalmitis may occur; use aseptic technique, monitor, and remove the implant if it occurs
- Retinal tears and detachment may occur; monitor and treat promptly; remove implant if vitrectomy with complete gas or silicone oil fill is required
請告知藥師或醫師您是否懷孕或哺乳、是否患有腎臟或肝臟疾病、是否有過敏，以及您正在使用的所有其他藥物或保健品。
同類別的其他藥品
常見問題
What is Revakinagene taroretcel used for?
Revakinagene taroretcel is a medicine in the class miscellaneous.
What side effects have been reported with Revakinagene taroretcel?
Conjunctival hemorrhage, Delayed dark adaptation, Foreign body sensation, Eye pain, Suture related complications, Miosis.
Can Revakinagene taroretcel be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. An eye implant of cells releasing ciliary neurotrophic factor (CNTF); no data in pregnant women, and not known if it raises CNTF above natural levels. CNTF under the skin caused no birth defects in rats or rabbits, but fewer implantations and live fetuses in rabbits. Use only if clearly needed. Breastfeeding: Unknown. No data on milk or infant effects; no LactMed record. Systemic exposure from the eye implant is not known to rise above natural CNTF levels. US label: weigh benefits of breastfeeding against the mother's need.
What does Revakinagene taroretcel interact with?
MediHelp does not list a checked interaction for Revakinagene taroretcel yet. Always tell your pharmacist about every medicine you take.
在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查
在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用，並使用劑量工具。
